Back to Search
Start Over
Cellular senescence and premature aging in Down Syndrome.
- Source :
-
Mechanisms of ageing and development [Mech Ageing Dev] 2023 Jun; Vol. 212, pp. 111824. Date of Electronic Publication: 2023 May 24. - Publication Year :
- 2023
-
Abstract
- Down syndrome (DS) is a genetic disorder caused by an extra copy of chromosome 21, resulting in cognitive impairment, physical abnormalities, and an increased risk of age-related co-morbidities. Individuals with DS exhibit accelerated aging, which has been attributed to several cellular mechanisms, including cellular senescence, a state of irreversible cell cycle arrest that is associated with aging and age-related diseases. Emerging evidence suggests that cellular senescence may play a key role in the pathogenesis of DS and the development of age-related disorders in this population. Importantly, cellular senescence may be a potential therapeutic target in alleviating age-related DS pathology. Here, we discuss the importance of focusing on cellular senescence to understand accelerated aging in DS. We review the current state of knowledge regarding cellular senescence and other hallmarks of aging in DS, including its putative contribution to cognitive impairment, multi-organ dysfunction, and premature aging phenotypes.<br />Competing Interests: Declaration of Competing Interest The authors declare no competing interests.<br /> (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Subjects :
- Humans
Cellular Senescence genetics
Comorbidity
Aging, Premature
Down Syndrome
Subjects
Details
- Language :
- English
- ISSN :
- 1872-6216
- Volume :
- 212
- Database :
- MEDLINE
- Journal :
- Mechanisms of ageing and development
- Publication Type :
- Academic Journal
- Accession number :
- 37236373
- Full Text :
- https://doi.org/10.1016/j.mad.2023.111824